<DOC>
	<DOCNO>NCT01818843</DOCNO>
	<brief_summary>Based study carbon monoxide human inflammatory beneficial physiological function , 'll go research application neonates .Phase 1 Study foundation test , safety Adverse reaction study newborn inhale CO</brief_summary>
	<brief_title>The Safety Adverse Reaction Study Neonatal Inhaled Carbon Monoxide</brief_title>
	<detailed_description>Previous study demonstrate , carbon monoxide show effectiveness inflammation , apoptosis well relaxation smooth muscle body . Now hypothesis use carbon monoxide pulmonary hypertension newborn , observe whether decrease pulmonary artery hypertension newborn . Phase 1 study , safety Adverse reaction study newborn inhale CO , , master application carbon monoxide dose</detailed_description>
	<mesh_term>Carbon Monoxide</mesh_term>
	<criteria>The newborn whose physiological function healthy close healthy Clinical consideration survive treatment value newborn Diagnosis congenital hereditary disease , child heart diseaseCentral pulmonary vascular malformation child</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Carbon monoxide</keyword>
	<keyword>safety</keyword>
	<keyword>Adverse Reaction</keyword>
	<keyword>newborn</keyword>
</DOC>